Background
==========

Asthma is a chronic inflammatory condition of the airways, variable airway obstruction and elevated serum IgE levels of unclear pathogenesis \[[@B1]\]. A hypothesis relating early vitamin D supplementation and induction of later allergy has initially been postulated as the main cholecalciferol metabolite calcitriol may suppresses dendritic cell maturation and consecutive development of Th1 cells \[[@B2]\] which is now supported by in vitro, animal and human studies \[[@B3],[@B4]\].

Exposure studies in humans, however, are difficult as nearly all newborns in Western countries are now being exposed in utero or during the first year of life to vitamin supplements \[[@B5],[@B6]\]. We now asked if there are DNA sequence variants that are associated with higher or lower levels of vitamin D metabolites. As it is unlikely that any complex disease is determined by variants in a single gene we tested the main genes that code for enzymes in the metabolic pathway of vitamin D conversion (Figure [1](#F1){ref-type="fig"}).

![Pathway diagram of genes tested for association.](1465-9921-7-60-1){#F1}

Methods
=======

Study population
----------------

The German Asthma Family Study collected affected sib pairs in 26 paediatric centres in Germany and Sweden for a two-stage genome-wide linkage scan \[[@B7],[@B8]\]. In these families at least two children were required with confirmed clinical asthma, while prematurity or low birth weight of the children were excluded, along with any other severe pulmonary disease. All affected children over age 3 had a history of at least 3 years of recurrent wheezing and with no other airway disease diagnosed. Unaffected siblings were also sampled if they were at least 6 years old and eligible for pulmonary function testing. Each study participant signed a consent form. All study methods were approved by the ethics commission of \"Ärztekammer Nordrhein-Westfalen\".

A complete pedigree of the family was drawn and information collected in a questionnaire. Participants were examined for several closely associated phenotypes. Pulmonary function tests were performed by forced flow volume tests and bronchial challenge was done by methacholine (discontinued in the second stage of the study) as reported earlier \[[@B7],[@B8]\].

The current analysis differs from previous publications \[[@B7],[@B8]\]. We excluded here all families with at least one member of non white skin colour (families 2, 14, 16, 19 to 21 and 27 to 32) as these individuals had considerable lower levels of 25-OH-D~3~(data not shown) compared to all other participants (Figure [2](#F2){ref-type="fig"}).

![Median, quartile and outlier of 25-OH-D~3~serum levels in 872 participants of the German Asthma Family Study with white skin colour by month of examination.](1465-9921-7-60-2){#F2}

Total IgE was determined with an ELISA (Pharmacia Diagnostics, Uppsala, Sweden). 25-OH-D~3~was determined with an enzymatic immunoassay (OCTEIA 25-Hydroxy Vitamin D kit, Immunodiagnostic Systems IDS, Frankfurt, Germany) that has a working range of 6--360 nmol/L, an intra-assay of 8% and inter-assay variation of 10% with a 100% specificity for 25-OH-D~3~and 75% specificity for 25-OH-D~2~according to the manufacturer. 1,25-OH2-D~3~was determined by immunoextraction followed by an enzyme-immunoassay (OCTEIA 1,25-Hydroxy Vitamin D kit, Immunodiagnostic Systems IDS, Frankfurt, Germany) that has a working range of 6--500 pmol/L, a 100% specificity for 1,25-OH~2~-D~3~and 0,009% specificity for 25-OH-D~2~. 25-OH-D~3~values reported are the mean of a duplicate analysis while due to limited serum availability only single assays have been performed for 1,25-OH~2~-D~3~.

Control population
------------------

191 anonymized DNAs were selected randomly from the ECRHS II study \[[@B9]\] to fill in remaining slots on the genotyping plates. These DNA samples served as population-based controls to test if the parents of the famillies had different allele spectrum.

DNA preparation and genotyping
------------------------------

DNA was isolated from peripheral white blood cells using Qiamp (Qiagen, Germany) or Puregene isolation kits (Gentra Systems, Minneapolis, MN, USA).

Genes were selected as coding either for key enzymes in the vitamin D conversion pathway or being regulated by vitamin D metabolites \[[@B10]\]. SNPs were being picked more or less randomly either for tagging haplotypes or being functional relevant \[[@B11]\]. Most SNPs were genotyped using MALDI-TOF mass spectrometry of allele-specific primer extension products generated from amplified DNA sequences (MassARRAY, SEQUENOM Inc., San Diego, CA, USA). A few SNPs were also genotyped at Illumina (San Diego CA, USA) by use of the Sentrix bead arrays. VDR \[[@B12]\] and IL4R \[[@B13]\] SNP results have been published earlier and are reanalysed here for the vitamin D levels. The following SNPs were analyzed (genotyping details upon request): rs3024498 (IL10), rs3024493 (IL10), rs1518111 (IL10), rs10000076 (IL10), rs1800872 (IL10), Il10-571CA (IL10), rs1800895 (IL10), rs1800894 (IL10), rs1800896 (IL10), rs1800893 (IL10), rs705120 (GC), rs222040 (GC), rs7041 (GC), rs4752 (GC), rs222011 (GC), rs221999 (GC), rs6811536 (SPP1), rs4754 (SPP1), rs1042714 (ADRB2), rs1800888 (ADRB2), rs1368439 (IL12B), rs3212227 (IL12B), rs2853697 (IL12B), rs3213119 (IL12B), rs2853696 (IL12B), rs2853694 (IL12B), rs2288831 (IL12B), rs3213096 (IL12B), rs2569254 (IL12B), rs3181216 (IL12B), rs3212220 (IL12B), rs3212218 (IL12B), rs1433048 (IL12B), rs2546890 (IL12B), rs3132299 (RXRA), rs877954 (RXRA), rs1045570 (RXRA), rs10500804 (CYP2R1), rs1562902 (CYP2R1), rs10766197 (CYP2R1), rs2853563 (VDR), rs731236 (VDR), rs7975232 (VDR), rs1544410 (VDR), rs2239185 (VDR), rs987849 (VDR), rs1540339 (VDR), rs3819545 (VDR), rs3782905 (VDR), rs2239186 (VDR), rs2228570 (VDR), rs1989969 (VDR), rs2853564 (VDR), hCV2880804 (VDR), rs238532 (CYP27B1), rs2072052 (CYP27B1), rs1048691 (CYP27B1), rs4646537 (CYP27B1), rs4646536 (CYP27B1), rs8176345 (CYP24A1), rs703842 (CYP27B1), I50V (IL4R), rs2234897 (IL4R), rs1805011 (IL4R), C406R (IL4R), rs1805015 (IL4R), Q551R (IL4R), rs1805016 (IL4R), rs10000306 (CARD15), rs2076753 (CARD15), rs2066842 (CARD15), rs2066843 (CARD15), rs2076756 (CARD15), rs10000331 (CARD15), rs3135499 (CARD15), rs3135500 (CARD15), rs375947 (IL12RB1), rs447009 (IL12RB1), rs436857 (IL12RB1), rs2045387 (IL12RB1), rs8118441 (CYP24A1), rs751089 (CYP24A1), rs6068816 (CYP24A1), rs4809958 (CYP24A1), rs2244719 (CYP24A1), rs2296241 (CYP24A1), rs17219266 (CYP24A1), rs6022999 (CYP24A1), rs17219315 (CYP24A1), rs11699278 (CYP24A1), rs2762942 (CYP24A1), rs2248137 (CYP24A1), rs2762943 (CYP24A1), rs2585427 (CYP24A1), rs2248359 (CYP24A1) and rs2426496 (CYP24A1).

Data handling and statistical analysis
--------------------------------------

Clinical data and genotypes were all transferred to a SQL 2000 database and checked for completeness, paternity, and Hardy-Weinberg equilibrium. Further analyses were performed using R 2.0 statistical software\[[@B14]\]. Linkage disequilibrium was determined by Haploview \[[@B15]\] using the Gabriel method for block definition. TDT association for quantitative and qualitative traits was done with SIBPAIR \[[@B16]\] using the TDT option for qualitative and the Haseman-Elston regression for quantitative traits. Family-based haplotype association analysis was performed by FBAT \[[@B17]\] using a dominant model.

Bioinformatics
--------------

SNP information was obtained from dbSNP \[[@B18]\], Innate Immunity PGA \[[@B19]\] and UCSC genome browser \[[@B20]\]. SNP selection was done with the help of Perlegen \[[@B21]\] and Hapmap \[[@B22]\] data. Sequence context annotation was done by SNPper \[[@B23]\], PUPA \[[@B24]\], TAMAL \[[@B25]\] and SNPPi \[[@B26]\]).

Results
=======

The total sample consisted of 947 individuals from 224 families where 872 serum measurements of 25-OH-D~3~, 876 1,25- OH~2~-D~3~and 934 total IgE measurements could be performed. After exclusion of non-white families 903 individuals from 201 families remained under analysis with 812 assays of 25-OH-D~3~, 807 1,25- OH~2~-D~3~and 903 total IgE.

Clinical details of the families are given in table [1](#T1){ref-type="table"}. Mean 25-OH-D3 level in children was 68 nmol/l (s.d. 38 nmol/l). 50% of values fell below and 17% above the Merck manual reference range of 62.4 to 99.8 nmol/l. Mean 1,25- OH~2~-D~3~in children was 102 pmol/l (s.d. 38 nmol/l). 3% of values fell below and 40% above the Merck manual reference range of 48.4 to 108 pmol/l. The highest measured value was 257 pmol/l in two children from unrelated families.

###### 

Clinical characteristics of the included 210 families of the German Asthma Family

                             Parents           Children
  -------------------------- ----------------- -----------------
  age/years)                 43.2/6.1          13.6/4.6
  female sex                 204/408 (50.0%)   207/474 (43.7%)
  height(cm)                 172.3/9.6         149.0/19.6
  weight(kg)                 76.4/15.1         42.8/17.2
                                               
  asthma diagnosis           99/408(24.3%)     416/474 (87.8%)
  Eczema                     51/382(13.4%)     184/448 (41.1%)
  allergic rhinitis          163/406 (40.1%)   280/474 (59.1%)
                                               
  D.pter. (D1) \> 0.5 kU/l   109/340 (32.1%)   243/422 (57.6%)
  D.far. (D2) \> 0.5 kU/l    103/341 (30.2%)   236/422 (55.9%)
  grass(GX1) \> 0.5 kU/l     129/340 (37.9%)   293/422 (69.4%)
  birch (T3) \> 0.5 kU/l     122/339 (36.0%)   213/423 (50.4%)
  mean positive RASTs        2.6/2.9           4.8/3.5
  Eosinophils 10^3^/μl       0.2/0.2           0.4/0.4
  IGE kU/l                   185.0/371.8       480.6/701.3
  mean RAST \> 0.5 kU/l      2.6/2.9           4.8/3.5

There were no major differences in serum levels between children and parents. There was also no major influence by sex or age. An important factor, however, was found with month of examination representing seasonal sun exposure in mid Europe (Figure [2](#F2){ref-type="fig"}). Even after serum storage of 10 years, the individual 25-OH-D~3~levels followed a clear time course with a major peak in August. The hormonal form 1,25-OH~2~-D~3~did not vary over the course of the year, as the conversion rate decreased with higher levels of 25-OH-D~3~(Figure [3](#F3){ref-type="fig"}).

![D-ratio (log(1,25-OH~2~-D~3~) \[pmol/l\]/log(25-OH-D3) \[nmol/l\]) versus 25-OH-D~3~in in 867 participants of the German Asthma Family Study with white skin colour.](1465-9921-7-60-3){#F3}

The overall heritability index H^2^for 25-OH-D~3~was 80.3% while the H^2^for 1,25-OH~2~-D~3~was only 30.0% \[[@B27]\]. There was neither an association of 25-OH-D3 and total IgE nor an association of 1,25-OH~2~-D~3~and total IgE levels.

13 genes were selected for genotyping (IL10, GC, SPP, ADRB2, IL12B, RXRA, CYP2R1, VDR, CYP27B1, IL4R, CARD15, IL12RB1, CYP24A1) and could be successfully completed for 96 SNPs. 4 of these SNPs were not in Hardy-Weinberg equilibrium: rs221999 (GC, P = 0,0299), rs10500804 (CYP2R1, P = 0,0498), rs10766197 (CYP2R1, P = 0,0100) and rs2248359 (CYP24A1, P = 0,0299). SNP rs221999 was also not in Hardy-Weinberg equilibrium in controls. The population-based controls showed similar allele frequencies compared to the family samples except for SNPs rs4754, rs2288831 and rs3819545.

SNP allele transmission in 7 of the tested 13 genes showed a p-value of less than 0.05 when testing for 25-OH-D~3~levels (IL10, GC, ADRB2, CYP2R1, IL4R, IL12RB1 and CYP24A1, see table [2](#T2){ref-type="table"}) while only 3 showed transmission disequilibrium with 1,25-OH2-D3 (IL10, IL12B and CYP24A1). SNPs in 5 genes showed a p-value \< 0.05 with asthma (IL10, IL12B, VDR, CARD15 and CYP24A1). Most significances, however, were weak. For 96 SNPs we would expect 4.8 tests to be positive for each trait which was exceeded by testing asthma (N = 8), total IgE (N = 13), 25-OH-D~3~(N = 8) but not 1,25-OH~2~-D~3~(N = 3). Only 2 SNP showed an effect with both traits, one in CYP2R1 (rs10766197) and one in IL4R (rs1805011). rs10766197 is situated in the CYP2R1 promotor; while rs1805011 is leading to an Ala- \> Glu amino acid exchange in the IL4 receptor.

###### 

Transmission approach: TDT results of 30 from 96 tested SNPs in 210 families of the German Asthma Family Study. Shown are only SNPs with at least one TDT results of p \< 0.05. The underlined 11 SNPs also appear in table 3.

  SNP                 Gene      Genomic position HG17   MAF    P asthma     P log(IgE)   P log(25- OH-D3)   P log(1,25- OH2-D3)
  ------------------- --------- ----------------------- ------ ------------ ------------ ------------------ ---------------------
  [rs3024498]{.ul}    IL10      1203329924              0,26   0,2654       0,4625       **0,0093**         0,4479
  rs1518111           IL10      1203333040              0,22   0,7087       **0,0487**   0,4962             0,6031
  rs10000076          IL10      1203334410              0,02   0,3711       0,2364       0,2374             **0,0030**
  Il10-571CA          IL10      1203334805              0,24   **0,0247**   0,3310       0,5889             0,3857
  rs1800895           IL10      1203334867              0,01   **0,0039**   0,5237       0,1152             0,3891
  rs1800894           IL10      1203335061              0,03   0,7773       0,5154       **0,0101**         0,1727
  rs222040            GC        4072981967              0,43   0,9211       **0,0163**   0,3829             0,0662
  rs7041              GC        4072983369              0,43   0,8812       **0,0249**   0,3884             0,0827
  rs221999            GC        4073014083              0,24   0,1475       0,2755       **0,0027**         0,1920
  rs1042714           ADRB2     5148186666              0,40   0,8532       0,8492       **0,0139**         0,7524
  [rs1433048]{.ul}    IL12B     5158688423              0,18   0,3452       0,5814       0,4184             **0,0339**
  [rs2546890]{.ul}    IL12B     5158692478              0,45   **0,0236**   0,9066       0,5667             0,1599
  [rs10500804]{.ul}   CYP2R1    11014866849             0,45   0,2242       **0,0418**   0,0833             0,8352
  [rs1562902]{.ul}    CYP2R1    11014874792             0,43   0,1342       **0,0443**   0,1063             0,8049
  [rs10766197]{.ul}   CYP2R1    11014878456             0,48   0,4700       **0,0284**   **0,0459**         0,7258
  rs7975232           VDR       12046525104             0,49   0,2484       **0,0400**   0,9235             0,9351
  [rs2239186]{.ul}    VDR       12046555677             0,19   **0,0350**   0,7521       0,9212             0,5459
  [rs1805011]{.ul}    IL4R      16027281373             0,11   0,2334       **0,0090**   0,1110             0,2684
  C406R               IL4R      16027281467             0,15   1,0000       **0,0255**   0,6542             0,1249
  rs1805015           IL4R      16027281681             0,16   0,8744       **0,0003**   0,4956             0,1197
  Q551R               IL4R      16027281901             0,25   0,2482       **0,0017**   0,9661             0,8287
  rs1805016           IL4R      16027282428             0,05   0,2076       **0,0082**   **0,0002**         0,7390
  rs10000306          CARD15    16049288266             0,04   0,6473       **0,0417**   0,4739             0,5429
  rs3135499           CARD15    16049323628             0,37   **0,0374**   0,2742       0,3929             0,8405
  rs2045387           IL12RB1   19018061586             0,24   0,6826       0,7907       **0,0145**         0,3191
  [rs2296241]{.ul}    CYP24A1   20052219626             0,50   **0,0046**   0,9291       0,8917             0,5098
  rs17219315          CYP24A1   20052221853             0,02   0,8658       0,6289       **0,0095**         0,3056
  rs2762942           CYP24A1   20052222332             0,04   0,7140       0,1506       0,2030             **0,0397**
  [rs2248137]{.ul}    CYP24A1   20052223150             0,39   **0,0256**   0,8250       0,2567             0,9096
  [rs2248359]{.ul}    CYP24A1   20052224925             0,36   **0,0158**   0,9302       0,2284             0,8510

In a next step we performed multivariate regression in the parental dataset while adjusting for age, sex, and month of examination (table [3](#T3){ref-type="table"}). This confirmed 11 SNPs already found in the family based-aproach; again, association results were weak. Some CARD15 variants had an asthma protective effect while IL12B SNPs carried risk alleles.

###### 

Case-control approach: Multivariate regression results of 31 from 96 tested SNPs in 408 parents of the German Asthma Family Study adjusted for age, sex and month of examination. Shown are only SNPs with at least one p \< 0.05 for heterocygotes and homocygote carriers of the minor allele. The underlined 11 SNPs also appear in table 2.

  SNP                 Gene      P asthma   P log(IgE)   P log(25-OH- D3)   P log(1,25-OH2-D3)                                                                                                                     
  ------------------- --------- ---------- ------------ ------------------ -------------------- -------- ----------- -------- ----------- -------- ----------- -------- ----------- -------- ----------- -------- -----------
  [rs3024498]{.ul}    IL10      0,132      0,837        -0,140             0,822                0,875    **0,034**   1,026    **0,011**   0,002    0,984       0,068    0,575       -0,022   0,819       0,014    0,883
  Il10571CA           IL10      1,731      **0,024**    1,225              0,080                0,446    0,362       0,241    0,608       0,171    0,290       0,252    0,110       -0,080   0,484       -0,090   0,421
  rs6811536           SPP1      0,215      0,632        0,266              0,555                0,532    0,069       0,687    **0,019**   0,159    0,112       0,149    0,136       -0,048   0,528       -0,038   0,623
  rs3213119           IL12B     -13,300    0,988        -13,765            0,988                2,221    0,149       2,950    **0,050**   -0,125   0,799       -0,124   0,795       -0,063   0,869       -0,090   0,808
  rs2853694           IL12B     -0,295     0,394        -0,845             **0,020**            0,212    0,288       0,272    0,216       -0,076   0,241       -0,092   0,200       0,069    0,173       0,003    0,952
  rs3181216           IL12B     0,729      0,058        0,972              **0,013**            -0,306   0,231       -0,300   0,238       0,086    0,322       0,191    **0,029**   0,090    0,180       0,051    0,446
  [rs1433048]{.ul}    IL12B     0,632      0,412        0,595              0,427                0,916    0,077       1,074    **0,034**   0,082    0,658       0,019    0,916       0,063    0,656       0,037    0,792
  [rs2546890]{.ul}    IL12B     -0,367     0,293        -0,808             **0,026**            0,166    0,391       0,272    0,199       -0,059   0,355       -0,074   0,291       0,002    0,969       -0,033   0,547
  rs3132299           RXRA      -15,303    0,986        -15,118            0,987                0,803    0,181       0,383    0,517       0,032    0,873       0,108    0,587       0,319    **0,042**   0,366    **0,018**
  rs877954            RXRA      -0,433     0,301        -0,258             0,551                0,345    0,163       -0,119   0,640       0,175    **0,029**   0,156    0,059       0,031    0,616       -0,003   0,965
  [rs10500804]{.ul}   CYP2R1    0,279      0,394        0,287              0,434                0,212    0,323       0,421    0,077       0,069    0,323       0,191    **0,014**   0,032    0,554       -0,001   0,982
  [rs1562902]{.ul}    CYP2R1    -0,071     0,846        0,020              0,960                -0,020   0,930       0,026    0,917       -0,108   0,143       -0,202   **0,011**   0,038    0,517       0,050    0,426
  [rs10766197]{.ul}   CYP2R1    -0,112     0,733        0,014              0,970                0,259    0,202       0,377    0,104       0,074    0,266       0,181    **0,017**   0,032    0,532       -0,018   0,757
  rs1544410           VDR       -0,105     0,786        -0,268             0,496                -0,350   0,145       -0,149   0,544       0,041    0,592       0,111    0,165       -0,120   **0,040**   0,047    0,441
  rs2239185           VDR       0,620      **0,041**    0,554              0,110                -0,184   0,352       -0,187   0,408       -0,022   0,730       -0,007   0,920       -0,110   **0,028**   -0,034   0,544
  [rs2239186]{.ul}    VDR       -0,274     0,669        0,289              0,641                0,638    0,121       0,558    0,160       -0,268   **0,040**   -0,163   0,193       -0,218   **0,036**   -0,156   0,119
  rs2228570           VDR       0,708      0,104        0,834              0,058                0,481    0,108       0,653    **0,029**   -0,100   0,279       -0,073   0,435       -0,042   0,537       -0,001   0,988
  rs238532            CYP27B1   -0,449     0,577        0,626              0,214                0,647    0,144       -0,075   0,813       -0,025   0,857       0,081    0,463       0,281    **0,009**   -0,063   0,456
  rs703842            CYP27B1   -0,467     0,316        -0,391             0,401                0,549    **0,036**   0,525    **0,045**   -0,041   0,631       0,046    0,589       -0,064   0,335       -0,022   0,738
  [rs1805011]{.ul}    IL4R      -13,530    0,986        -13,774            0,986                -2,094   **0,024**   -1,752   0,053       0,559    **0,049**   0,497    0,073       0,193    0,382       0,212    0,329
  rs2076753           CARD15    -1,152     **0,044**    -1,300             **0,023**            0,093    0,738       0,137    0,625       0,062    0,483       0,057    0,526       0,000    0,998       -0,059   0,397
  rs2066842           CARD15    -1,260     **0,028**    -1,416             **0,013**            -0,039   0,884       0,083    0,757       0,037    0,669       0,014    0,871       0,028    0,673       -0,038   0,560
  rs2066843           CARD15    -1,221     **0,033**    -1,301             **0,023**            -0,066   0,813       0,055    0,842       0,007    0,939       0,010    0,912       0,016    0,819       -0,041   0,544
  rs2076756           CARD15    -1,396     **0,031**    -1,427             **0,027**            -0,142   0,627       0,073    0,800       0,077    0,410       0,055    0,552       0,035    0,627       -0,029   0,680
  rs375947            IL12RB1   1,012      **0,011**    0,580              0,125                0,117    0,653       0,087    0,733       0,133    0,116       0,063    0,443       0,140    **0,027**   -0,011   0,858
  rs2244719           CYP24A1   0,257      0,407        -0,029             0,931                -0,045   0,817       0,184    0,389       0,139    **0,029**   0,025    0,723       0,165    **0,001**   0,114    **0,031**
  [rs2296241]{.ul}    CYP24A1   0,042      0,889        0,548              0,125                0,101    0,609       -0,018   0,934       0,160    **0,012**   0,030    0,669       -0,058   0,236       0,039    0,463
  [rs2248137]{.ul}    CYP24A1   -0,104     0,776        -0,253             0,503                0,320    0,145       0,117    0,609       0,038    0,599       -0,024   0,748       -0,120   **0,028**   -0,131   **0,021**
  rs2762943           CYP24A1   15,934     0,986        15,861             0,986                -3,140   **0,041**   -3,193   **0,036**   -0,146   0,763       -0,195   0,684       -0,878   **0,018**   -0,784   **0,033**
  [rs2248359]{.ul}    CYP24A1   -0,109     0,793        -0,460             0,245                0,230    0,345       0,057    0,805       -0,023   0,766       -0,019   0,803       -0,137   **0,025**   -0,112   0,056
  rs2426496           CYP24A1   0,415      0,403        -0,091             0,848                -0,045   0,886       -0,225   0,464       0,207    **0,038**   0,165    0,091       -0,060   0,436       -0,076   0,314

Haplotypes were constructed from all significantly associated SNPs (table[2](#T2){ref-type="table"}). No significant association was found in any of the 13 genes except for CYP24A1 where a 5-point frequent haplotype (rs2296241:rs17219315:rs2762942:rs2248137:rs2248359) spanning both LD blocks of CYP24A1 was associated with a diagnosis of asthma (p = 0.001), total IgE (p = 0.001), 25-OH~2~-D~3~(p = 0.004) and 1,25-OH~2~-D~3~serum level (p = 0.005, table [4](#T4){ref-type="table"}).

###### 

CYP24A1 haplotype transmission results in 213 families of the German Asthma Family Study. Haplotype was formed from all SNPs with p \< 0.05 in the TDT (table 2).

                                  h1          h2          h3      h4      h5      h6     h7
  ------------------ ------------ ----------- ----------- ------- ------- ------- ------ -------
  SNP                rs2296241    G           A           A       G       G       A      A
                     rs17219315   A           A           A       A       A       A      G
                     rs2762942    A           A           A       G       A       A      A
                     rs2248137    C           G           C       C       G       G      G
                     rs2248359    C           T           C       C       T       C      T
  frequency                       0,40        0,31        0,15    0,04    0,03    0,03   0,02
                                                                                         
  asthma             Z value      3,42        -2,11       -1,43   0,10    NA      NA     NA
                     P value      **0,001**   **0,035**   0,153   0,919   NA      NA     NA
  log(IgE)           Z value      3,19        -1,97       -1,26   -0,46   0,71    NA     -0,79
                     p value      **0,001**   **0,049**   0,208   0,645   0,478   NA     0,432
  log(25-OH-D3)      Z value      2,85        -2,25       -1,03   0,08    1,59    NA     -0,22
                     P value      **0,004**   **0,025**   0,305   0,935   0,112   NA     0,823
  log(1,25-OH2-D3)   Z value      2,83        -1,94       -1,38   0,10    1,50    NA     -0,09
                     p value      **0,005**   0,052       0,167   0,922   0,134   NA     0,932

Discussion
==========

We have shown that serum 25-OH-D~3~(calcidiol) levels -although highly influenced by environmental sunlight exposure- is a heritable trait in asthma families. In contrast, a major genetic influence on 1,25-OH~2~-D~3~(calcitriol) levels could not be found, a finding that requires replication in further family and population-based studies.

The reason for this discrepancy is not fully clear as the conversion of 25-OH-D~3~to 1,25-OH~2~-D~3~is closely regulated by a direct feedback loop. It is generally agreed, however, that 25-OH-D~3~reflects best the current vitamin D status \[[@B28]\]. Unfortunately standardized reference values for this age group are not available but values for 25-OH-D~3~in children seem to be in the upper normal range \[[@B29]\]. An explanation therefore could be that a delayed downstream metabolism is leading to an (unintended) afflux or -also possible- that an increased peripheral demand needs a larger reservoir.

We observed a number of positive associations with single nucleotide polymorphisms. Although the selection of candidate genes was rather subjective, it turned out that some of the tested candidate genes are associated with both allergy and vitamin D metabolites. Statistical significance, however, was weak, and varied even with different analysis strategies and software packages (unpublished own observation). There was also no fully consistent pattern when comparing the family transmission and the case-control approach which makes it unlikely that any of the tested SNPs is already an important functional variant. The new associations may instead indicate the effects of physically closely related variants in these genes (which is also supported by the haplotype results of CYP24A1).

The associated candidate genes are of particular interest. CYP24A1 is the major enzyme of the calcitriol degradation pathway that showed nearly 100-fold increase after vitamin D treatment of rats \[[@B30]\]. Previous studies also suggest that CYP24A1 null mice cannot clear calcitriol efficiently \[[@B31]\] which would support the above mentioned afflux hypothesis. An alternative splicing variant in CYP24A1 has been described recently \[[@B32]\] leading to a truncated and catalytically dysfunctional protein while it is unclear if any of our tested SNPs will have functional relationship to this protein variant. Dark skinned Asian Indians seem to have increased 24-hydroxylase activity compared to white skinned Caucasians \[[@B33]\] whereas both skin colour and metabolic capacity seem to be adapted to less sun light exposure in Caucasians.

The evidence that the human CYP2R1 is a key vitamin D 25-hydoxylase is rather new \[[@B34]\] where the identity of the hepatic 25-hydroxylase has remained unclear for several decades. At least six CYPs can catalyze this step where the most viable candidates are CYP27A1 and CYP2R1 \[[@B34]\] with the renal enzyme responsible for 1-α-hydroxylation being CYP27B1. A loss of function mutation in CYP2R1 has also been described \[[@B34]\] and deserves further testing.

Variants in CYP2R1, CYP27B1 and CYP24A1 or other genes in the metabolic pathway of vitamin D have not been tested so far with asthma or allergy but several of the VDR-controlled genes tested here already have been associated with asthma and allergy. These include IL12B \[[@B35]-[@B37]\], IL12RB \[[@B38],[@B39]\], IL10 \[[@B40]\], VDR \[[@B41],[@B42],[@B12]\], GC \[[@B43]\], ADRB2 \[[@B44]\], CARD15 \[[@B45]\] and IL4R \[[@B46]\].

Of these, IL12B is a particular interesting cytokines. Macrophage engulfed microorganism are leading to IL12p70 production, a heterodimer of IL12p40 (IL12B) and IL12p35 (IL12A), which is a primary inducer of Th~1~cell development and a critical factor in the development of allergy \[[@B47]\]. Also IL10 seems to be important where production in circulating T cells from atopic asthmatics is maximally stimulated \[[@B48]\]; allergen specific IL10 producing T regulatory cells can inhibit allergen specific effector cells and represent an important line of defense in the allergic reaction \[[@B49]\]. Functional variants in these genes leading to human disease are not known so far.

The many positive but weak associations represent a common dilemma in complex disease. In asthma more than 75 genes have now been claimed to be associated \[[@B50]\] but none of them has been shown to contribute to risk in all populations studied \[[@B51]\]. Obviously there are only small genetic effects and a large heterogeneity; sometimes there is unidentified population stratification and there might be phenotyping and genotyping errors. Most likely, however, not the \"center\" SNPs have been choosen \[[@B11]\]. The current pathway based approach seems to be an alternative in particular when an environmental trait can be included. It is likely that some of the genes identified here are acting in concert to determine the overall vitamin D sensitivity.

Besides increasing sample size and testing additional populations, further work may concentrate on monitoring vitamin D supplementation by immunological readouts and the identification of contributing functional genetic elements. The present rediscovery of a genetic vitamin D sensitivity \[[@B52]\] may be an important step in allergy induction and also surmount many other diseases including type 1 diabetes, osteoporosis, tuberculosis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases, and prostate cancer where adequate vitamin D support has been found to be beneficial.
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D~3~= cholecalciferol, vitamin D

25-OH-D~3~= calcidiol

1,25-OH~2~-D~3~= calcitriol

CYP24A1 = cytochrome P450, family 24, subfamily A, polypeptide 1

VDR = nuclear vitamin D receptor

IL12B = interleukin 12 B (cytotoxic lymphocyte maturation factor 2, p40)

RXRA = retinoid X receptor α

IL4R = interleukin 4 receptor

ADRB2 = ß2 adrenergic receptor

IL12RB1 = interleukin 12 receptor, ß1

IL10 = interleukin 10

GC = group-specific component (vitamin D binding protein)

CYP2R1 = cytochrome P450, family 2, subfamily R, polypeptide 1

CARD15 = caspase recruitment domain family, member 15 (NOD2)

SPP1 = secreted phosphoprotein 1, osteopontin (OPN, ETA-1, BNSP,\...)

CYP27B1 = cytochrome P450, family 27, subfamily B, polypeptide 1
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